Back to results
US 11,951,100 B2Granted
Formulations of RBP4 inhibitors and methods of use
AssigneeBelite Bio, Inc
InventorsYu-Hsin Tom Lin, Cheng-Chi Irene Wang
Life of this patent
Estimating the term…
Abstract
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as macular degeneration and the like.
Claims20
A polymorph of a compound of Formula (I) having the structure:
- wherein the polymorph exhibits an X-ray powder diffraction (XRPD) pattern having at least three characteristic peaks expressed in degrees two theta (+/−0.5 degree theta) at 6.7, 9.3, 14.1, 17.2, 23.5, 27.1, and 29.0.
A method of treating an eye disease, the method comprising administering a therapeutically effective amount of a pharmaceutical composition, the composition comprising a polymorph of a compound of Formula (I) having the structure:
- wherein the polymorph exhibits an X-ray powder diffraction (XRPD) pattern having at least three characteristic peaks expressed in degrees two theta (+/−0.5 degree theta) at 6.7, 9.3, 14.1, 17.2, 23.5, 27.1, and 29.0.
Dependencies are inferred from the claim text.